Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
Advancement in novel target detection using improved molecular cancer biology has opened up new avenues for promising anti-cancer drug development. In the past two decades, the mechanism of tumor hypoxia has become more understandable with the discovery of hypoxia-inducible factor-1α (HIF-1α). It is...
Main Authors: | Rituparna Ghosh, Priya Samanta, Rupali Sarkar, Souradeep Biswas, Prosenjit Saha, Subhadip Hajra, Arijit Bhowmik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/16/5192 |
Similar Items
-
Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature
by: Diego Rodriguez, et al.
Published: (2021-08-01) -
HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
by: Eloy Moreno Roig, et al.
Published: (2019-01-01) -
A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update
by: Anuja Gajanan Magar, et al.
Published: (2024-03-01) -
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
by: Leah Davis, et al.
Published: (2022-02-01) -
Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity
by: Antonio Bouthelier, et al.
Published: (2020-12-01)